It has long been suspected that sensory signal transmission is inhibited in the mammalian brain during sleep. We hypothesized that Ca v3.1 T-type Ca 2؉ channel currents inhibit thalamic sensory transmission to promote sleep. We found that T-type Ca 2؉ channel activation caused prolonged inhibition (>9 s) of action-potential firing in thalamic projection neurons of WT but not Ca v3.1 knockout mice. Inhibition occurred with synaptic transmission blocked and required an increase of intracellular Ca 2؉ . Furthermore, focal deletion of the gene encoding Ca v3.1 from the rostral-midline thalamus by using Cre͞loxP recombination led to frequent and prolonged arousal, which fragmented and reduced sleep. Interestingly, sleep was not disturbed when Ca v3.1 was deleted from cortical pyramidal neurons. These findings support the hypothesis that thalamic T-type Ca 2؉ channels are required to block transmission of arousal signals through the thalamus and to stabilize sleep.
It has long been suspected that sensory signal transmission is inhibited in the mammalian brain during sleep. We hypothesized that Ca v3.1 T-type Ca 2؉ channel currents inhibit thalamic sensory transmission to promote sleep. We found that T-type Ca 2؉ channel activation caused prolonged inhibition (>9 s) of action-potential firing in thalamic projection neurons of WT but not Ca v3.1 knockout mice. Inhibition occurred with synaptic transmission blocked and required an increase of intracellular Ca 2؉ . Furthermore, focal deletion of the gene encoding Ca v3.1 from the rostral-midline thalamus by using Cre͞loxP recombination led to frequent and prolonged arousal, which fragmented and reduced sleep. Interestingly, sleep was not disturbed when Ca v3.1 was deleted from cortical pyramidal neurons. These findings support the hypothesis that thalamic T-type Ca 2؉ channels are required to block transmission of arousal signals through the thalamus and to stabilize sleep.
insomnia ͉ ␣1G ͉ thalamus ͉ arousal ͉ Cre recombinase E ach year, 60 million Americans experience frequent or extended periods of insomnia characterized by difficulty initiating or maintaining sleep. Understanding how sleep is produced should provide insight into insomnia and identify targets for its treatment.
Sensory perceptions and motor responses are blunted during sleep. Because sensory and motor signals are relayed to and from the cerebral cortex through the thalamus, inhibition of thalamocortical signal transmission could play an important role in achieving stable sleep. Consistent with this notion, the firing response of thalamic projection neurons to visual stimulation is suppressed during sleep in primates (1) 
Although not yet shown, visceral sensory signals (e.g., respiration), which relay through midline thalamus, represent a potent arousal signal and, therefore, may also be suppressed to facilitate sleep (2) . The molecular and cellular basis for sensory suppression during sleep and its potential role in preventing arousal have not been well studied.
One potential mechanism for sensory inhibition is the marked increase of T-type Ca 2ϩ channel-mediated Ca 2ϩ transients observed in thalamus during sleep (3, 4) . Thalamic neurons hyperpolarize during sleep, causing T-type Ca 2ϩ channels to deinactivate and enabling their activation with excitatory input (4) (5) (6) . Ca v 3.1 is the major T-type Ca 2ϩ channel transcript in thalamic projection neurons, where it is required for lowthreshold Ca 2ϩ spikes and action-potential bursts (7) (8) (9) . Interestingly, in animals with Ca v 3.1 T-type Ca 2ϩ channel globally deleted pain-evoked action-potential firing in thalamic neurons of the ventrobasal nucleus is increased (9) . The cellular mechanism of this Ca v 3.1 control of action-potential firing is difficult to deduce based on data from a global knockout (KO) because Ca v 3.1 is very broadly expressed throughout the brain. Nevertheless, the finding led us to hypothesize that thalamic Ca v 3.1 may inhibit action-potential firing directly and that this inhibition may serve to stabilize sleep.
To assess the role of Ca v 3.1 in thalamic projection neurons, we examined its effect on action-potential firing in vitro. To determine whether this thalamic function of Ca v 3.1 plays a role in sleep, we selectively deleted the gene from thalamic projection neurons and examined vigilance states by recording the electroencephalogram (EEG) and electromyogram (EMG). We found that Ca v 3.1 activation initiates a prolonged inhibition of actionpotential firing in thalamic projection neurons in vitro. We also found that targeted deletion of Ca v 3.1 gene in thalamocortical neurons destabilizes sleep.
Materials and Methods
General Animal Handling. Mice were housed in a pathogen-free environment regulated at 21-23 C under a 12:12-h light͞dark schedule (lights on from 7 a.m. to 7 p.m.). All procedures relating to animal care and treatment were approved by the Massachusetts Institute of Technology and Harvard Medical School Institutional Animal Care and Use Committees, and they conformed to institutional and National Institutes of Health guidelines. suprageniculate, and paratenial). Moderate staining was observed in other thalamic nuclei: anteroventral, anterodorsal, ventral lateral, ventral anterior, parafascicular, and posterior thalamic group. Weak staining was observed in lateral posterior, dorsal lateral geniculate, medial geniculate, and ventral posterior thalamic nuclei. Strong recombination was observed also in ventral medial and dorsal medial hypothalamic nuclei, pontine reticular nucleus, mesencephalic fifth, and 12th cranial nerve nuclei. Moderate recombination was also present in the superficial piriform cortex, indusium griseum, dorsal endopiriform nucleus, medial and median preoptic hypothalamic nuclei, medial vestibular nucleus, ventral cochlear nucleus, nucleus of trapezoid body, and abducens nucleus. Very small numbers of neurons expressed in the lateral septum, locus coeruleus, substantia nigra pars reticulata, and parabrachial nucleus.
Construction of Floxed T-Type Calcium Channel Cav3.1. A BAC clone containing the Ca v 3.1 gene was isolated from a mouse C57BL͞6 genomic BAC clone library (Genome Systems) and confirmed by PCR, T͞A cloning, and sequencing. Restriction mapping, Southern blot hybridization, and subcloning and ligation were used to create a replacement vector for homologous recombination in ES cells. Briefly, a 7-kb EcoRV-PstI fragment containing exons 9-13 was used. A loxP sequence was placed into a SpeI site 5Ј of exon 9. An LFNT cassette (containing a loxP sequence) was placed into a SpeI site 3Ј of exon 12 to produce an Ϸ2.5 kb of loxP-flanked genomic DNA and a 1.5-kb 5Ј and 3-kb 3Ј flanking sequence. A diptheria toxin A gene (DT-A) was placed at a site flanking the targeting construct for negative selection (16) . An LFNT cassette (K. Nakazawa and S.T., unpublished data) was modified to delete a TK cassette (LFNT-TK). A pair of FRT sites (recognition sequences for a yeast-derived, site-specific Flp recombinase) that flank PGK-Neo (for positive selection) and a 3Ј loxP sequence remained after deletion of TK. The PGK-Neo cassette was deleted after germline transmission by crossing to a Flp deleter transgenic mouse (17) . The ''floxed'' Ca v 3.1 mice ( fCa v 3.1) were crossed to a global Cre deleter (K9-Cre; M.P.A. and S.T., unpublished data), a thalamic Cre deleter (K128-Cre), or a cortical Cre deleter (CW2-Cre, CAMKII␣ promoter driving cortical and hippocampal CA1 pyramidal neuron expression) (18) .
Histocytochemistry. Mice were perfused with ice-cold 4% paraformaldehyde in PBS buffer. For X-gal staining, brains were removed and postfixed at 4°C for 30 min. Coronal sections (50 m thick) were cut on a Vibratome in PBS. Sections were incubated in 0.1 M PBS containing 0.01% SDS, 0.02% Nonidet P-40, and 2 mM MgCl 2 at 4°C for 15 min, followed by ␤-galactosidase reaction in 1 PBS (pH 8.0) containing 0.5 mg͞ml X-gal, 5 mM K 4 Fe(CN) 6 ͞3H 2 O, 5 mM K 3 Fe(CN) 6 , and 2 mM MgCl 2 at 37°C for 24 h. For alkaline phosphatase staining, sections were heat-inactivated in PBS at 70°C for 1 h, equilibrated with a reaction buffer (100 mM Tris⅐HCl, pH 9.5͞100 mM NaCl͞50 mM MgCl 2 ͞0.1% Tween 20͞2 mM levamisole; Vector Laboratories) for 15 min at room temperature and incubated with 0.4 mg/ml nitroblue tetrazolium chloride͞0.19 mg/ml 5-bromo-4-chloro-3-indolyl-phosphate͞100 mM Tris, pH 9.5͞50 mM MgSO 4 (NBT͞BCIP tablets; Roche Molecular Biochemicals) at room temperature for 10-20 min. Section were postfixed in 10% formalin for 2 h and stained with nuclear fast red (Polysciences).
In Situ Hybridization. Terminal deoxyribonucleotidyl transferase (Invitrogen) and ATP [ 33 P] (New England Nuclear) labeled the following set of 33-bp antisense oligonucleotides: 5Ј-AGAGCAGCCCAAGATGACGTGGAGGCCATGCCG-3Ј, 5Ј-TCTGAAAGACAGTGACAATGGCCCAGAGCAGGG-3Ј, 5Ј-GCCGA AGGGACCGTAGACGAGCAGCT TCA-GCAG-3Ј, and 5Ј-ATTCTTCCGGTCTGGCAACGTGTCC-CCATCCCG-3Ј. Probes were designed to hybridize sequences flanked by loxP sequences and to be minimally homologous to other channels. Unincorporated nucleotides were removed on Sephadex G-50 spin columns (Pharmacia). Hybridization buffers, temperatures, and wash stringency were performed as described by Talley et al. (19) . Slides were exposed to film (Hyperfilm ␤-MAX, Amersham Biosciences) for 1 week and analyzed for relative intensity by using image-analysis software (MCID, Imaging Research, St. Catherine's, ON, Canada). For resolution of cellular labeling, slides were dipped in liquid autoradiography emulsion (NTB2, Kodak, Sigma-Aldrich), exposed for 5-9 weeks, and examined by dark-field and bright-field microscopy. Nissl counterstain was used.
Implantation of EEG͞EMG Electrodes. Under anesthesia with ketamine͞xylazine (100͞10 mg͞kg, injected i.p.), screw electrodes were implanted into the skull (1-mm anterior to bregma and 1-mm anterior to lambda, 1.5-mm lateral to midline). EMG electrodes (AS633; Cooner Wire, Chatsworth, CA) were inserted into neck extensor muscles. Leads were attached to a 2 ϫ 2-pin header secured to the skull by using dental acrylic. An activity transmitter (TA-F20; Data Sciences International, St. Paul, MN) was placed into the peritoneal cavity.
Sleep Recordings. Recordings were performed under a 12:12-h light͞dark schedule (lights on from 7 a.m. to 7 p.m.). Mice were habituated for 10 days to a counterbalanced, light-weight cable connected to a low-torque commutator (4-TBC-9-S; Crist Instrument, Hagerstown, MD), affixed to the center of the top of the cage. Signals from EEG͞EMG electrodes were amplified and bandpass-filtered by using model 12 amplifiers (Grass Instruments, Quincy, MA). EEG signals were amplified ϫ5,000 and bandpass-filtered at 0.3-30 Hz. EMG signals were amplified ϫ5,000 and bandpass filtered at 2-100 Hz. Both signals were acquired digitally at 128 Hz by using Sleep Sign (Kissei Comtec, Matsumoto, Japan). Behavioral state was scored in 10-s epochs as wake, rapid-eye-movement (REM), or non-REM (NR) sleep by using automated methods, followed by visual screening by a blinded single examiner (20) .
Submerged Slice Patch Clamp Recording. Mice were anesthetized by using isoflurane, and the brains were submerged into 4°C sucrose solution (250 mM sucrose͞5 mM KCl͞10 mM glucose͞25 mM sodium bicarbonate͞5 mM KCl͞1.25 mM NaH 2 PO 4 ͞1 mM CaCl 2 ͞5 mM MgSO 4 ͞95% O 2 ͞5% CO 2 (carbogen gas). Coronal sections (250 m) were prepared on a Vibratome Plus 3000 (Vibratome, St. Louis, MO) in 4°C sucrose. Slices were incubated at 35°C for 30 min and then at room temperature for Ͻ8 h in an interface chamber containing ACSF buffer (125 mM NaCl͞25 mM glucose͞25 mM sodium bicarbonate͞2.5 mM KCl͞1.25 mM NaH 2 PO 4 ͞2 mM CaCl 2 ͞1 mM MgCl 2 ͞95% O 2 ͞5% CO 2. Recordings were performed at room temperature by using infrared-guided whole-cell patch-clamp technique. Data were acquired with an EPC10 triple patch clamp amplifier and acquisition system (HEKA, Lambrecht, Germany). Slices were recorded in rapidly flowing (1 ml͞min), carbogen-perfused ACSF on the stage of an upright microscope fitted with differential interference contrast (DIC) optics and camera (Optical Analysis, Nashua, NH).
T-Type Calcium Channel Current Measurements. Whole-cell, voltage clamp was performed with 1 M tetrodotoxin͞30 M bicuculline͞1 mM 4-aminopyridine͞10 mM tetraethylammonium (TEA) chloride͞2 mM cesium chloride in the ACSF. The pipette contained 90 mM cesium methanesulfonate, 11 mM cesium chloride, 0.5 mM magnesium dichloride, 0.5 mM CaCl 2 , 10 mM Hepes, 11 mM EGTA, 4 mM magnesium⅐ATP, 0.3 mM Tris⅐GTP, and 7 mM Tris⅐phosphocreatine (pH 7.3; Tris base).
Ca 2؉ Spike and Action-Potential Measurements. Current clamp studies were performed with 10 M CNQX and 30 M bicuculline in ACSF. The pipette contained 135 mM potassium gluconate, 4 mM KCl, 2 mM NaCl, 10 mM Hepes, 4 mM magnesium⅐ATP, 0.3 mM Tris⅐GTP, and 7 mM Tris⅐phosphocreatine (pH 7.25; Tris base). In some experiments, the following drugs were added to the bath: cAMP agonist forskolin (10 M) or TEA chloride (4 mM). BAPTA (15 mM) was substituted for equimolar potassium gluconate in the pipette.
Statistical Analysis. Statistical analysis was conducted by using STATVIEW (SAS Institute, Cary, NC). Data were analyzed by two-tailed t test, ANOVA, or repeated-measures ANOVA. Values in graphs were expressed as mean Ϯ SEM.
Results

Generation of Mice for Gene Manipulations in Thalamus.
Ca v 3.1 T-type calcium channels were focally deleted from a subset of adult neurons by using the bacteriophage P1-derived Cre͞loxP-recombination system (11) (Figs. 1A and 2 A) . To delete loxPflanked sequences selectively in thalamic projection neurons, we placed the Cre recombinase gene under control of the promoter sequences for the potassium channel K v 3.2 (K v 3.2-Cre; Fig. 1 A) . The K v 3.2 promoter was chosen because the transcript is first expressed Ϸ12 days after birth and is highly restricted (Ͼ90% of transcript) to thalamic projection neurons (21) .
K128-Cre, a mouse line containing the K v 3.2-Cre transgene, was found to express Cre recombinase activity strongly in rostral-midline thalamic projection neurons. By crossing K128-Cre to two Cre recombinase-dependent reporters [Z͞AP, which labels cellular membranes with alkaline phosphatase (Fig. 1  B-D) , and Rosa26, which labels cellular nuclei with ␤-galactosidase (Fig. 1 E-G)] , we established the cell type and regional (Fig. 1B) . The neurons displayed a multipolar dendritic arbor (Fig. 1B) , and a dense axonal projection to reticular thalamic nucleus (Fig. 1C) , and superficial and deep layers of cortex (Fig. 1D) . Using the Rosa26 reporter (Fig. 1 E-G) , the K128-Cre transgene was found to recombine selectively in rostral and midline thalamic nuclei despite the broad thalamic expression of native K v 3.2 (see Materials and Methods for details). Recombination was also observed in superficial layers of piriform cortex, ventromedial and dorsomedial hypothalamic nuclei (Fig. 1 E-G) . The complete pattern of recombination is described in Materials and Methods. The results demonstrate that K128-Cre transgene deletes loxP-flanked sequences strongly in rostral-midline thalamic projection neurons. To focally delete Ca v 3.1, loxP sequences were placed into introns flanking exons 9-12 of the gene encoding Ca v 3.1 in C57͞BL6 mouse embryonic stem cells by using homologous recombination ( Fig. 2A) . Exons 9-12 were deleted by crossing homozygous loxP-flanked mice ( fCa v 3.1͞fCa v 3.1) to Cre transgenic mice including a global Cre deleter (K9-Cre), a thalamic Cre deleter (K128-Cre), and a cortical Cre deleter (CW2-Cre, targets cortical pyramidal neurons, 18). In situ hybridization to Ca v 3.1 mRNA showed a WT pattern of expression in homozygous fCa v 3.1 mice (Fig. 2 B and D) (19) and a complete loss of transcript with global deletion (Fig. 2C) . Mice from the thalamic Cre deleter cross showed a marked reduction of Ca v 3.1 mRNA in rostral-midline thalamus but normal expression in cortex (Fig. 2E) . Mice from the cortical Cre deleter cross showed decreased Ca v 3.1 mRNA transcript in cerebral cortex but no change in the thalamus (Fig.  2F ). This genetic approach allows cell-type-and regionrestricted deletion of Ca v 3.1 from the thalamus by using K128-Cre and from the cortex by using CW2-Cre.
T-type Ca 2ϩ channel-mediated Ca 2ϩ transients increase in thalamic projection neurons during sleep (22) , but the purpose of this increase is unknown. To define the function of these currents, we first confirmed that this current in thalamic projection neurons depends on Ca v 3.1 (Fig. 5 , which is published as supporting information on the PNAS web site), as reported (8) . We then examined the effects of Ca v 3.1 activation on actionpotential firing.
T-Type Ca 2؉ Channel Cav3.1 Activation Inhibits Action-Potential Firing.
Transient hyperpolarization, which activates Ca v 3.1, inhibited action-potential firing in neurons of WT mice. By contrast, this stimulus had no effect on neurons from global Ca v 3.1 KO mice. Nonadapting action-potentials were observed under baseline conditions, in some cases, or with depolarizing current injections ( Fig. 3 A and B) . These action potentials were inhibited by a transient (1 s) hyperpolarizing current injection for Ͼ9 s (Fig. 3A  a and b) in neurons of WT mice. Repeated hyperpolarization every 9 s revealed that inhibition duration depended on currentinjection size (Fig. 3A b-d ) and was reversible (Fig. 3Ad) . In neurons from global Ca v 3.1 KO mice (Fig. 3 B and C) , inhibition was abolished.
Tonic hyperpolarization, which also deinactivates Ca v 3.1, inhibited evoked action-potential firing in thalamic projection neurons of WT but not global Ca v 3.1 KO mice. Depolarizing current injections in hyperpolarized WT neurons (V m ϭ Ϫ80 mV; Fig. 3D , left traces), evoked a low-threshold Ca 2ϩ potential, a brief action-potential burst, and a plateau of membranepotential depolarization that evoked no further action potentials. In contrast, the same conditions evoked a continuous train of action potentials in global Ca v 3.1 KO neurons. Depolarizing current injections evoked a continuous train of action potentials in neurons of both genotypes when left at resting membrane potential (V m ϭ Ϫ55 to Ϫ60 mV; Fig. 3D, right traces) . Comparing the action-potential firing rates evoked from a holding potential of Ϫ80 mV and Ϫ55 to Ϫ60 mV, we observed inhibition in WT but not global Ca v 3.1 KO mice (Fig. 3E) . The results indicate that one of the major Ca v 3.1 functions is to inhibit action-potential firing.
This Ca v 3.1-mediated inhibition of action-potential firing does not occur through GABAergic feedback (23, 24) . First, AMPA and GABA A synaptic transmissions were blocked (10 M CNQX and 300 M bicuculline) in our experiments. Second, no inhibitory synaptic currents were observed in the tracings. Third, action-potential inhibition was blocked, but action-potential bursts were preserved in neurons exposed to an intracellular calcium chelator (BAPTA; Fig. 3E ), a nonselective potassium channel blocker (TEA chloride; Fig. 3C ), and an agent that increases intracellular cAMP (forskolin; Fig. 3E ). The data suggest that Ca v 3.1 activation inhibits action-potential firing through a Ca 2ϩ -dependent, TEA-inhibited, and cAMPregulated pathway.
Based on our current findings that thalamic Ca v 3.1 T-type Ca 2ϩ channel activation inhibits action-potential firing and the evidence for increased thalamic T-type Ca 2ϩ channel activity during sleep (22) , we hypothesized that thalamic Ca v 3.1 may be necessary for well maintained sleep. Consistent with this hypothesis, mice with global or thalamic Ca v 3.1 deletion displayed fragmented sleep. The vigilance-state hypnograms during the rest (light) period showed frequent brief awakenings (W) that interrupted NR sleep in KO mice (Fig. 4A) . During the light period, global and thalamic KO mice had more total wake bouts (Fig. 4B) , mainly because of an increase of brief (20-40 s) wake bouts (bout histogram analysis, data not shown). Because of these frequent awakenings, NR bouts were much shorter (Fig.  4B, right graph) . Mice with cortical Ca v 3.1 deletion, by contrast, showed no disruption of sleep (Fig. 4 A and B) . All mice showed . 3 . Cav3.1 T-type calcium channel activation inhibits Na ϩ action-potential firing. A hyperpolarizing current injection (1 s) caused prolonged inhibition of Na ϩ action potentials in neurons of WT (A-C) (n ϭ 13), but not global Cav3.1 KO (B and C) (n ϭ 16), mice. Cells were obtained from lateral dorsal thalamic nucleus, and they displayed a multipolar dendritic arbor. (C) TEA (4 mM) blocks inhibition in WT neurons (P Ͻ 0.002, repeated-measures ANOVA, n ϭ 5 each). (D) Depolarizing current injections, in hyperpolarized neurons (Ϫ80 mV, left traces), evoked a Ca 2ϩ potential and brief Na ϩ action-potential burst in WT (n ϭ 12͞12) but no Ca 2ϩ potential (n ϭ 0͞15) and persistent Na ϩ actionpotential firing in KO (n ϭ 15͞15). Ca 2ϩ potential activation and Na ϩ actionpotential inhibition are missing with current injections to neurons held at Ϫ55 to Ϫ60 mV (right traces). (E) The ratio of Na ϩ action-potential firing frequencies evoked by current injections from Ϫ80 vs. Ϫ55 to Ϫ60 mV revealed inhibition in WT (n ϭ 7), but not KO (n ϭ 7), neurons. Inhibition was blocked in WT neurons perfused with intracellular BAPTA (15 mM, n ϭ 9) or extracellular forskolin (10 M, n ϭ 6). Current pulses are shown below the traces. * , P Ͻ 0.02; ** , P Ͻ 0.01, unpaired t test.
normal amounts and durations of REM sleep (Fig. 4B ). The results demonstrate that loss of thalamic Ca v 3.1 causes frequent brief arousals that fragment sleep.
Mice with global or thalamic Ca v 3.1 deletion also had difficulty sleeping during the dark period. All mice displayed decreased NR sleep immediately after the lights were turned off (Fig. 4 C and D) . However, after this Ϸ30-min wake period, WT mice slept, but global and thalamic KO mice remained awake for up to 6 h ( Fig. 4C and Fig. 6 , which is published as supporting information on the PNAS web site). Consequently, sleep onset was delayed (latency to sleep: WT, 28 Ϯ 28 min; thalamic Ca v 3.1 deletion, 226 Ϯ 58 min; mean Ϯ SE; P Ͻ 0.003, unpaired t test), and total sleep was reduced (Fig. 4D , total NR sleep: WT, 11 h 24 Ϯ 16 min; thalamic Ca v 3.1 deletion, 9 h 54 min Ϯ 19 min; mean Ϯ SE; P ϭ 0.003, unpaired t test). In contrast, cortical Ca v 3.1 KO mice had only a mild delay in sleep onset (latency to sleep: cortical Ca v 3.1 deletion, 85 Ϯ 19 min; mean Ϯ SE; P Ͻ 0.02, unpaired t test, compared with WT) and had normal amounts of total sleep (Fig. 4B, P inhibits action potentials through an intracellular pathway involving increases of intracellular Ca 2ϩ . This gating of thalamic action potentials is defective in global Ca v 3.1 KO mice. We have also shown that Ca v 3.1 T-type Ca 2ϩ channel function is required in the thalamus, but not in the cerebral cortex to achieve normal patterns of sleep. Mice with thalamic Ca v 3.1 deletion experience frequent arousals from sleep. During the dark period, these mice also experience sleep loss because of a delayed sleep onset. Based on these findings, we suggest Ca v 3.1 T-type Ca 2ϩ channels inhibit the transmission of thalamic action potentials to prevent feedforward excitation, which could destabilize activity within the neural circuitry maintaining the sleep state (28) .
Inhibition of thalamic transmission may occur during various conditions that activate Ca v 3.1. A feedback-inhibitory pathway has been identified (23, 24) that interconnects neurons of the thalamic relay and reticular nuclei. Based on the Ͼ9 s inhibition that we observed, GABAergic synaptic inputs from the reticular nuclei could be transformed into a prolonged inhibition by Ca v 3.1. Thalamic projection neurons also display various spontaneous rhythmic activities that are thought to involve T-type Ca 2ϩ channels (29, 30) . One purpose of these rhythmic activities may be to activate Ca v 3.1 and, thereby, provide a continuous inhibition of transmission independent of GABAergic signaling.
Ca v 3.1 inhibits action potentials through a TEA-sensitive, Ca 2ϩ -dependent and cAMP-inhibited intracellular pathway. The sensitivity to a potassium channel blocker, TEA, the slow kinetics of inhibition, and the dependence on Ca 2ϩ suggest the slow after hyperpolarization current (sAHP) may be responsible. This potassium current is activated slowly by Ca 2ϩ and inhibited by the cAMP-dependent protein kinase, consistent with our observations (31) .
Although some recombination occurred outside the thalamus, the intense pattern of Ca v 3.1 deletion observed in rostralmidline thalamus in K128-Cre suggests that this region may normally carry arousal signals that disrupt sleep (2, 32) . Alternatively, the midline (intralaminar) thalamic nuclei may produce Ca v 3.1-mediated action-potential bursts during sleep that excite reticular thalamic neurons to provide feedforward inhibition to other thalamic nuclei (33) .
Some researchers have speculated that thalamic bursts produced by the T-type Ca 2ϩ channel may underlie the cortical EEG waves observed during sleep (4, 5) . We were surprised to find that cortical EEG power within the delta frequency range (1-4 Hz) was not significantly reduced but, rather, was moderately increased (data not shown). The observation suggests that other systems (e.g., intracortical circuits or basal forebrain GABAergic projections; ref. 34 ) drive the delta waves of the cortical EEG during sleep. We speculate that this delta-wave-generating system may be critical to the maintenance of sleep when thalamic sensory filtering by Ca v 3.1 is defective.
The pattern of brief arousals in Ca v 3.1 KO mice resembles the sleep-microstructure alterations recently recognized in patients with insomnia and other sleep disorders of arousal (35) . It remains to be established whether these mice rouse from sleep because of inappropriate transmission of normal sensations or because of pathologic sensations like those in sleep apnea or periodic limb movement disorder. If these brief arousals from sleep in Ca v 3.1 KO mice were caused by inadequate gating of sensory stimuli, it would possibly provide a perspective on human insomnia in which relatively mild sensations can disrupt sleep.
